Diagnostic accuracy of Murray law-based quantitative flow ratio in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Heart and Vessels · 2024
DOI: 10.1007/s00380-024-02387-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart and Vessels, 2024. Verfasst von Fukuishi Yuta und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe,…. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Fractional Flow Reserve, Myocardial, Severity of Illness Index. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Murray law-based quantitative flow ratio (μQFR) is a novel computational method that enables accurate estimation of fractional flow reserve (FFR) using a single angiographic projection. However, its diagnostic value in patients with severe aortic stenosis (AS) remains unclear. METHOD: We included 25 consecutive patients who underwent transcatheter aortic valve replacement (TAVR) for severe AS with intermediate or greater (30-90%) coronary artery disease (CAD). Pre- and post-TAVR μQFR, QFR, instantaneous flow reserve (iFR), and post-TAVR invasive FFR values were measured. We evaluated the diagnostic performance of pre-TAVR μQFR, QFR, and iFR using post-TAVR FFR ≤ 0.80 as a reference standard of ischemia. RESULT: Pre-TAVR μQFR was significantly correlated with post-TAVR FFR (r = 0.73, p < 0.0001). The area under the curve of pre-TAVR μQFR on post-TAVR FFR ≤ 0.8 was 0.91 (95% confidence interval [CI] 0.77-0.98), comparable to that of pre-TAVR iFR (0.86 [95% CI 0.71-0.98], p = 0.97). The accuracy, sensitivity, specificity, and positive and negative predictive values of pre-TAVR μQFR on post-TAVR FFR ≤ 0.8 were 84.2% (95% CI 68.7-93.4), 61.6% (95% CI 31.6-86.1), 96.0% (95% CI 79.6-99.9), 88.9% (95% CI 52.9-98.3), and 82.8% (95% CI 70.6-90.6), respectively. For pre-TAVR iFR, these values were 76.5% (95% CI 58.8-89.3), 90.9% (95% CI 58.7-99.8), 69.6% (95% CI 47.1-86.8), 58.8% (95% CI 42.8-73.1), and 94.1% (95% CI 70.8-99.1), respectively. CONCLUSION: μQFR could be useful for the physiological evaluation of patients with severe AS with concomitant CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. hotake@med.kobe-u.ac.jp.
Zitieren
APA
Yuta, F., Kawamori, H., Toba, T., Hiromasa, T., Sasaki, S., Hamana, T., Fujii, H., Osumi, Y., Iwane, S., Yamamoto, T., Naniwa, S., Sakamoto, Y., Matsuhama, K., Hirata, K. I., & Otake, H. (2024). Diagnostic accuracy of Murray law-based quantitative flow ratio in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Heart and Vessels. https://doi.org/10.1007/s00380-024-02387-5
Vancouver
Yuta F, Kawamori H, Toba T, Hiromasa T, Sasaki S, Hamana T, et al. Diagnostic accuracy of Murray law-based quantitative flow ratio in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Heart and Vessels. 2024. doi:10.1007/s00380-024-02387-5
BibTeX
@article{Yuta2024,
author = {Yuta, Fukuishi and Kawamori, Hiroyuki and Toba, Takayoshi and Hiromasa, Takashi and Sasaki, Satoru and Hamana, Tomoyo and Fujii, Hiroyuki and Osumi, Yuto and Iwane, Seigo and Yamamoto, Tetsuya and Naniwa, Shota and Sakamoto, Yuki and Matsuhama, Koshi and Hirata, Ken-Ichi and Otake, Hiromasa},
title = {Diagnostic accuracy of Murray law-based quantitative flow ratio in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement},
journal = {Heart and Vessels},
year = {2024},
doi = {10.1007/s00380-024-02387-5}
}
EUVIMED